Ascend Wellness Sets August 28 Vote on 1-for-10 to 1-for-50 Reverse Split to Enable Uplisting

summarizeSummary

Ascend Wellness Holdings filed a definitive proxy for an August 28 special meeting to vote on a reverse stock split ranging from 1-for-10 to 1-for-50, aiming to lift its $0.41 share price to meet exchange listing requirements.

check_boxKey Events · Corporate Governance and Compliance · AAWH

• Reverse Split Vote Set for August 28

  Shareholders will vote on a reverse stock split at a ratio between 1-for-10 and 1-for-50, with the board choosing the final ratio. The meeting will be held virtually on August 28, 2026, with a record date of July 7, 2026.

• Uplisting Is the Stated Goal

  The reverse split is intended to raise the stock price above the minimum bid requirement for a NYSE American or Nasdaq listing. At $0.41, a 1-for-10 split would imply a $4.10 post-split price, while a 1-for-50 split would imply $20.50.

• Cannabis Federal Illegality Remains a Barrier

  The proxy warns that even if the price hurdle is met, national securities exchanges have not listed companies engaged in adult-use cannabis activities under current federal law. A legal or policy change, or a corporate restructuring, would be needed.

• Board Discretion and Abandonment Option

  The board may abandon the reverse split at any time before it becomes effective if it determines the split is no longer in the company's best interests. The authorization expires one year from the meeting or upon exchange listing, whichever is earlier.

auto_awesomeAnalysis · AAWH · Life Sciences

Ascend Wellness Holdings is asking shareholders to approve a reverse stock split at a ratio between 1-for-10 and 1-for-50, with the board retaining discretion to choose the final ratio. The primary goal is to boost the stock price above the minimum bid requirement for a NYSE American or Nasdaq listing. With shares trading at $0.41, the company needs a roughly 5x to 10x price increase to meet typical $2–$5 listing thresholds. The board warns that federal cannabis prohibition may still block any exchange listing even if the price hurdle is cleared. The special meeting is set for August 28, 2026, with a record date of July 7, 2026. This follows a June 25 preliminary proxy and a recent quorum reduction to one-third, signaling management is lining up governance changes to secure approval.